In Pharmalot (11/6), columnist Ed Silverman
discusses how the outcome of the upcoming election will impact the FDA. Steve
Grossman of the Alliance For A Stronger FDA non-profit, says that the FDA is
not part of the election campaign dialogue. Grossman says this is a good thing,
since "any intelligent discussion requires a long-term perspective and a
mastery of detail and nuance, both of which are in short supply during sound
bite-oriented politicking." However, he notes that the FDA will ultimately
be affected by the election. Silverman asserts that the notion that the FDA
"would largely continue on its current path with an Obama re-election is
not hard to imagine. ... With Romney in the White House, however, the agency is
likely to look and feel quite differently – and have a commish who is willing
to 'swing the pendulum' away from an emphasis on safety and take any number of
steps to speed approvals, regardless of budget cuts."
DIA Daily is a digest of the most important news selected from
thousands of sources by the editors of BulletinHealthcare. The presence of
content or advertising does not endorse, nor imply endorsement of, any products
or services by the Drug Information Association. Neither BulletinHealthcare nor
the Drug Information Association is liable for the use of or reliance on any
information contained in this briefing.
If you would like more information about, or
have a question pertaining to, DIA Membership and its benefits, please email membership@diahome.org.
Click here to check your membership status.
Drug Information
Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
No comments:
Post a Comment